The present invention relates generally to the field of collection and dispensing of fluids, and more particularly to a syringe plunger having a hinged flange for application of pressure on the plunger and for hanging the plunger.
Syringe pumps, or drivers, are small infusion pumps used to gradually administer fluids from a syringe to a patient. When administering drugs (e.g. painkillers, antiemetics, etc.) syringe pumps prevent periods during which the medication levels in the blood are too high or too low, and prevent a patient from having to repeatedly take tablets or pills. Additionally, syringe pumps are effective at administering medication over many minutes or hours and often reduce errors by caretakers. One particular use of syringe pumps is in the field of enteral feeding administration. For example, syringe pumps are especially useful for the administration of breast milk (or suitable substitutes), formula, medication, nutritional supplements or other enteral fluids in the care and treatment of neonatal children.
Syringes can also be used with gravity feed systems, for example, when administering nutrients and/or medications to a neonatal patient. When administering fluids to a patient via a gravity-feed system, the syringe plunger can be removed from the syringe body to prevent a vacuum from developing inside the syringe as the fluid leaves the syringe and enters the patient. The removal of the plunger from the syringe body is often seen as a drawback to this process and requires that a user take special care in storing the plunger while the syringe is being utilized. In the past, users have strapped the plunger to the syringe body or otherwise stored the plunger on a sterile tray or other location to avoid permanently separating these components. Removing the plunger from the syringe body can expose the contents of the syringe to unwanted pathogens, dust or other foreign matter, which can be harmful to a patient.
To alleviate the need for removing the plunger from the syringe to allow for venting, syringes have been developed to provide venting while at least a portion of the plunger is still engaged with the syringe, for example, so that the drawbacks of potentially exposing the plunger to unwanted pathogens, dust or foreign matter is eliminated. U.S. Published patent application Ser. No. 13/231,185, Patent Application Publication No. US 2012/0071853 and U.S. Published patent application Ser. No. 14/614,156, Patent Application Publication No. US 2015/0148753, show vented syringes for use with gravity feed systems, which are hereby incorporated herein by reference for all purposes.
When administering fluids to a patient via a gravity feed system, it is generally desirable to hang the syringe and plunger assembly at a position above the patient that is receiving the fluids from the syringe. Some syringes may include a handle mounted to the syringe body for permitting hanging. Alternatively, a hole or tether can be provided on a flange of a syringe plunger for hanging the syringe. U.S. Published patent application Ser. No. 14/224,297, Patent Application Publication No. US 2014/0207098, shows a vented syringe plunger including a tether provided thereon, which is hereby incorporated herein by reference for all purposes.
In some instances, modifications made to a syringe to allow for hanging for use with gravity feed applications can negatively affect compatibility of the syringe with metering pumps. Thus, it can be seen that needs exist for improved syringes having a plunger that can be utilized for hanging in gravity-feed applications, and that is compatible with metering pumps in applications.
It is to the provision of a syringe having a hinged plunger flange meeting these and other needs that the present invention is primarily directed.
The present invention relates to a syringe having a hinged plunger flange, which allows the syringe to be compatible for use with a metering pump when the hinged plunger flange is in a down, pump compatible position and for use in hanging the syringe when the hinged plunger flange is in a second position, for example, an upright or expanded configuration.
In one aspect, the invention relates to a syringe having a plunger for movably mounting within a syringe cavity, the plunger including a first end and a second end, and a middle body portion extending between the first and second ends, wherein a sealing head is provided at the first and a contact face is provided at the second end, wherein the contact face comprises a fixed portion and a flange portion movable relative to the fixed portion between an open configuration and a closed configuration, wherein in the open configuration an IV hook or other engagement member can engage an opening formed in the flange portion.
In another aspect, the invention relates to a syringe plunger for movably mounting within a syringe barrel. The plunger includes a first end and a second end, and a middle body portion extending between the first and second ends. In example embodiments, a sealing head is provided at the first end and a contact face is provided at the second end, wherein the contact face includes a fixed portion mounted to the middle body portion and a flange portion mounted to the fixed portion and movable relative to the fixed portion between an open configuration and a closed configuration. In example embodiments, in the open configuration an IV hook or other engagement member can engage an opening formed in the flange portion.
In another aspect, the invention relates to a syringe plunger for movably mounting within a syringe barrel. The syringe plunger includes a contact face including a hinged portion and a fixed portion, wherein the hinged portion is pivotally coupled to the fixed portion and movable between an open configuration and a closed configuration, wherein in the open configuration an opening is accessible for receiving a hanging support member
In yet another aspect, the invention relates to a syringe including a syringe barrel and a syringe plunger adapted to advance and retract within the syringe barrel. The syringe plunger includes a contact flange with a hinged portion movable between a retracted position adapted for use with a syringe pump or manual actuation, and an extended position adapted for hanging from a support.
These and other aspects, features and advantages of example embodiments of the invention will be understood with reference to the drawing figures and detailed description herein, and will be realized by means of the various elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following brief description of the drawings and detailed description of the invention are exemplary and explanatory of preferred embodiments of the invention, and are not restrictive of the invention, as claimed.
The present invention may be understood more readily by reference to the following detailed description of the invention taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Any and all patents and other publications identified in this specification are incorporated by reference as though fully set forth herein.
Also, as used in the specification including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment.
With reference now to the drawing figures, wherein like reference numbers represent corresponding parts throughout the several views,
According to example forms, the syringe is optionally a vented syringe, having one or more vents allowing fluid passage between the syringe barrel and plunger, such that the plunger is movable between a vented position and a sealed/vacuum position. U.S. Published patent application Ser. No. 13/231,185, Patent Application Publication No. US 2012/0071853; U.S. Published patent application Ser. No. 14/224,297, Patent Application Publication No. US 2014/0207098; and U.S. Published patent application Ser. No. 14/614,156, Patent Application Publication No. US 2015/0148753, are hereby incorporated herein by reference, and show example vented syringes for use with gravity feed systems, the vented syringe barrels of which may be adapted to receive a syringe plunger having a hinged pressure flange according to example embodiments of the present invention.
In example embodiments, the syringe plunger 10 comprises a first or distal end 12 and a second or proximal end 14. The distal end 12 comprises a sealing head 16 for tightly engaging an inner wall of a cavity of a syringe body with a fluid tight seal, and the proximal end 14 comprises a pressure plate, thumb pad or contact face 20 to engage a depressor of a syringe pump (or permit user manipulation by hand operation). A main body portion 22 of the plunger 10 generally connects the first end 12 to the second end 14. In example forms, the main body portion 22 generally comprises one or more planar ribs 24 connecting the sealing head 16 to the contact face 20. In one form, the main body portion 22 comprises generally uniform ribs 24 having a cruciform cross-section in the shape of a plus (+) sign. Optionally, cross-sections of other desired shapes and configurations can be chosen as desired. As shown in
As depicted in
In example embodiments, a living hinge 60 is provided between the fixed and flange portions 30, 50 of the syringe plunger 10 such that the two portions are generally integrally formed together with a thin web of flexible material extending therebetween, allowing for hinged movement of the flange portion 50 relative to the fixed portion 30, for example, between a closed, flat, collapsed or retracted position (see
According to example embodiments, the flange portion 50 comprises two end extensions or arms 52 that are generally offset from one another and a middle section or central connection portion 54 connecting together top portions of the two arms 52, for example, to form a generally upside-down U-shaped member. In example forms, the contact face or pressure plate 20 is generally circular in shape, and thus, the middle section 54 and outer portions of the arms 52 are generally arcuate or radiused to match the profile of the contact face. As depicted in
In example embodiments, opposite sides of the central member 40 of the fixed portion 30 comprise channels 42 for receiving and providing coupling interengagement with the ledges 64 of the arms 52 of the flange portion 50. Generally, the features of the upper surfaces of the fixed and flange portions are matching such that in the retracted configuration the contact face is completed and can be used normally (e.g., for compressing in a pump or grasping for moving the plunger relative to the syringe barrel). In example embodiments, the upper surfaces of the fixed and flange portions 30, 50 comprise gripping or surface features in the form of a linear array of ribs or channels. For example, the fixed portion 30 comprises one or more surface features 47 and the flange portion comprises surface features 72. Optionally, other surface features can be provided as desired.
In example embodiments, as shown in
Referring back to
In example embodiments, the contact face 120 at the second end 114 comprises a fixed portion 130 and a hinged hanging flange portion 150 that is movable relative to the fixed portion 130. According to example forms, the flange portion 150 is connected to the fixed portion 130 by a plurality resiliently flexible living hinges 164, for example, about 9 separate hinges. Optionally, more or less hinges can be provided as desired. In example embodiments, the fixed portion 130 generally comprises a portion of a complete disc-shaped contact face, and the flange portion 150 comprises the other portion of the complete disc-shaped contact face, and wherein the flexible living hinges 164 generally extend between an end face 134 of the fixed portion 130 and an end face 166 of the flange portion 150, for example, such that the flange portion 150 is movable between the collapsed configuration (
As shown in
In example embodiments, flange portion 130 can comprise one or more holes, slots or other openings 160 formed therein for receiving an IV hook or other engagement member for suspending the plunger and an attached syringe. In the depicted embodiment shown in
In use, the hinged portion of the contact flange of the syringe plunger is positioned in its flat or retracted position for use with a syringe S when using a syringe pump SP or for manual actuation of the syringe (see
According to one example form, the packaged plunger (e.g., before being opened by an end user) is generally configured such that the hinged portion is in its flat or retracted position. According to example embodiments, for example in the case when the plunger is molded with the hinged portion in the upright or extended position, the home position of the hinged flange is generally in the flat, retracted position, for example, which can be manipulated with one or more fingers or thumb, and for compatible use with a metering pump. According to some example embodiments, after the manufacture thereof for example in the case where the plunger is plastic injection molded with the flange being in the upright configuration, one or more of the molded plungers can be directed to an assembly line or feeding machine whereby one or more machines and/or operators move the flange portion from the upright configuration to the collapsed configuration, for example, such that the plunger, when assembled individually or with the syringe, is packaged with the flange in the collapsed configuration. Alternatively, in the case where the plunger is assembled with the syringe prior to packaging of the assembly, the plunger with the flange in the upright configuration can be assembled with the syringe and then the assembly can be moved through an automated process whereby a portion of the syringe is captured by a machine or fixture which in turn performs one or more steps to move the flange portion of the contact face from the upright configuration to the collapsed configuration. Optionally, an individual can grab the assembled syringe and plunger and manually move the flange portion from the upright configuration to the collapsed configuration.
While the invention has been described with reference to preferred and example embodiments, it will be understood by those skilled in the art that a variety of modifications, additions and deletions are within the scope of the invention, as defined by the following claims.
This application claims the priority benefit of U.S. Provisional Patent Application Ser. No. 62/299,604 filed Feb. 25, 2016, the entirety of which is hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3026872 | Prater, Jr. | Mar 1962 | A |
3113873 | Krause | Dec 1963 | A |
3581928 | St. Amand | Jun 1971 | A |
3731684 | Spiegel | May 1973 | A |
3880311 | McPhee | Apr 1975 | A |
3885562 | Lampkin | May 1975 | A |
3900184 | Burke et al. | Aug 1975 | A |
3910273 | Arlers | Oct 1975 | A |
4153056 | Silver | May 1979 | A |
4356824 | Vazquez | Nov 1982 | A |
D267536 | Findlay | Jan 1983 | S |
4392851 | Elias | Jul 1983 | A |
4413741 | Curchack | Nov 1983 | A |
4460143 | Ohama | Jul 1984 | A |
D282807 | Hasse | Mar 1986 | S |
D282962 | Gerber | Mar 1986 | S |
D307795 | Frantz | May 1990 | S |
4994048 | Metzger | Feb 1991 | A |
5137511 | Reynolds | Aug 1992 | A |
5137527 | Miller et al. | Aug 1992 | A |
D330862 | Shibley et al. | Nov 1992 | S |
5202533 | Vandersteen | Apr 1993 | A |
5279566 | Kline, Jr. et al. | Jan 1994 | A |
5460603 | DeSantis | Oct 1995 | A |
5549550 | Mazer et al. | Aug 1996 | A |
5611787 | Demeter et al. | Mar 1997 | A |
5746715 | Mazer et al. | May 1998 | A |
5746733 | Capaccio et al. | May 1998 | A |
5755689 | Mazer et al. | May 1998 | A |
5779668 | Grabenkort | Jul 1998 | A |
5832971 | Yale et al. | Nov 1998 | A |
5843042 | Ren | Dec 1998 | A |
6019747 | McPhee | Feb 2000 | A |
6029946 | Doyle | Feb 2000 | A |
6036669 | Cole et al. | Mar 2000 | A |
6065649 | Scoggins | May 2000 | A |
6277092 | Cole et al. | Aug 2001 | B1 |
D447797 | Odell et al. | Sep 2001 | S |
6290206 | Doyle | Sep 2001 | B1 |
D461243 | Niedospial, Jr. | Aug 2002 | S |
6482170 | Andersen | Nov 2002 | B1 |
6541802 | Doyle | Apr 2003 | B2 |
6752790 | Coombs | Jun 2004 | B2 |
6766917 | Blewitt, III | Jul 2004 | B1 |
6962563 | Yasunaga | Nov 2005 | B2 |
7118554 | Sibbitt | Oct 2006 | B2 |
D552773 | Greenberg | Oct 2007 | S |
D578210 | Muta et al. | Oct 2008 | S |
7560686 | Bisch et al. | Jul 2009 | B2 |
D618347 | Bradshaw | Jun 2010 | S |
7842217 | Enns et al. | Nov 2010 | B2 |
7846131 | Hudson et al. | Dec 2010 | B2 |
D632144 | Weisenbach | Feb 2011 | S |
D635249 | Becker | Mar 2011 | S |
7921847 | Totz | Apr 2011 | B2 |
7955315 | Feinberg et al. | Jun 2011 | B2 |
7980131 | Barton | Jul 2011 | B2 |
D646531 | Murphy | Oct 2011 | S |
8053721 | Bisch et al. | Nov 2011 | B2 |
D654584 | Costello et al. | Feb 2012 | S |
D654585 | Costello et al. | Feb 2012 | S |
8162916 | Knight | Apr 2012 | B2 |
8231597 | Knight | Jul 2012 | B2 |
8366697 | Knight | Feb 2013 | B2 |
8540683 | Williams, Jr. et al. | Sep 2013 | B2 |
8550418 | Gesler, III | Oct 2013 | B2 |
8715244 | Prechtel et al. | May 2014 | B2 |
8777900 | Hershey et al. | Jul 2014 | B2 |
8992488 | Ingram et al. | Mar 2015 | B2 |
9301587 | D'Amico | Apr 2016 | B2 |
9333288 | Hilliard et al. | May 2016 | B2 |
9433562 | Ingram et al. | Sep 2016 | B2 |
9433729 | Ingram et al. | Sep 2016 | B2 |
20030014005 | Chiba | Jan 2003 | A1 |
20040054350 | Shaughnessy et al. | Mar 2004 | A1 |
20060264824 | Swisher, III | Nov 2006 | A1 |
20070060898 | Shaughnessy et al. | Mar 2007 | A1 |
20070123822 | Wang et al. | May 2007 | A1 |
20070265579 | Kleyman et al. | Nov 2007 | A1 |
20080097348 | Itrich | Apr 2008 | A1 |
20080183153 | Enns | Jul 2008 | A1 |
20080255501 | Hogendijk et al. | Oct 2008 | A1 |
20080255523 | Grinberg | Oct 2008 | A1 |
20090287161 | Traub et al. | Nov 2009 | A1 |
20100249719 | Fojtik | Sep 2010 | A1 |
20110046568 | Enns et al. | Feb 2011 | A1 |
20110184383 | Hasegawa | Jul 2011 | A1 |
20110192489 | Pobitschka | Aug 2011 | A1 |
20110270227 | Kleckner et al. | Nov 2011 | A1 |
20120071853 | Ingram | Mar 2012 | A1 |
20120150111 | Hershey et al. | Jun 2012 | A1 |
20130082057 | Schiff et al. | Apr 2013 | A1 |
20130131606 | Bertocci | May 2013 | A1 |
20140039462 | Ingram et al. | Feb 2014 | A1 |
20140213985 | Teucher et al. | Jul 2014 | A1 |
20150148753 | Ingram et al. | May 2015 | A1 |
20160287798 | Holmqvist | Oct 2016 | A1 |
Number | Date | Country |
---|---|---|
2108381 | Aug 1972 | DE |
29617949 | Apr 1997 | DE |
0481250 | Sep 1991 | EP |
1110568 | Jun 2001 | EP |
1980282 | Oct 2008 | EP |
1126718 | Jun 1955 | FR |
2007095541 | Aug 2007 | WO |
2009141510 | Nov 2009 | WO |
2011026156 | Mar 2011 | WO |
2012037082 | Mar 2012 | WO |
Entry |
---|
International Search Report & Written Opinion for PCT/US2011/051338; dated Feb. 15, 2012; 20 pgs. |
International Search Report & Written Opinion for PCT/US2012/60987; dated Jan. 25, 2013; 13 pgs. |
International Search Report & Written Opinion for PCT/US2013/53631; dated Oct. 11, 2013; 10 pgs. |
International Search Report & Written Opinion for PCT/US2017/018957; dated May 15, 2017; 10 pgs. |
NeoMed Enteral Syringe; 2007; 1 pg. |
Number | Date | Country | |
---|---|---|---|
20170246087 A1 | Aug 2017 | US |
Number | Date | Country | |
---|---|---|---|
62299604 | Feb 2016 | US |